RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,974,000 | +186.5% | 433,924 | +414.2% | 0.26% | +125.4% |
| Q1 2020 | $689,000 | -54.7% | 84,391 | +1.7% | 0.11% | -28.8% |
| Q4 2019 | $1,522,000 | +23.0% | 83,008 | -25.6% | 0.16% | +24.0% |
| Q3 2019 | $1,237,000 | -18.9% | 111,624 | -25.6% | 0.13% | -14.0% |
| Q2 2019 | $1,525,000 | – | 149,946 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |